AFLIBERCEPT IN COMBINATION WITH DOCETAXEL FOR SECOND-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC): FINAL RESULTS OF A MULTINATIONAL PLACEBO-CONTROLLED PHASE III TRIAL (EFC10261-VITAL)

Tarih
2011
Yazar
Bennouna, Jaafar
Ozguroglu, Mustafa
Baldotto, Clarissa
Shepherd, Frances A.
Scagliotti, Giorgio
Novello, Silvia
Ramlau, Rodryg
Gorbunova, Vera A.
Ciuleanu, Tudor E.
GÖKSEL, TUNCAY
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/121232
Koleksiyonlar